Please assess the completion status of the following clinical trial:

Trial Title: Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* solid tumor with radiological diagnosis of spinal metastases~* pain score minimum 2 on 11-point scale~* maximum of 2 consecutive or noncontiguous spinal vertebra involved by tumor at current level of interest~* No or mild neurological signs (radiculopathy, dermatomal sensory change and muscle strength of involved extremity)~* Karnofsky performance ≥60~* WHO ≤2~* life expectancy \> 6 weeks~* age ≥18~* non-pregnant, non-lactating female patients~Exclusion Criteria:~* history of previous radiotherapy to the spine at current level of interest~* spinal instability or neurological deficit~* pathological fracture or impending fracture needing fixation~* prior surgery to the spine at current level of interest~* clinical signs of spinal cord compression or severe neurological deficits~* patients with a pacemaker such that MRI cannot be performed or the treatment cannot be delivered safely~* patients unable to undergo MRI~* earlier nuclear medicine treatment~* pregnancy~* altered mental status that would prohibit the understanding and giving of informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): Conventional radiotherapy, 1x8Gy
- Arm 2 (Type: EXPERIMENTAL): Stereotactic radiotherapy, 1x20Gy

Based on this trial design, predict the completion outcome and termination type (if applicable).